Dosage forms and therapeutic uses L-4-chlorokynurenine
First Claim
Patent Images
1. A method of treating depression comprising the step of orally administering to a human patient in need thereof a therapeutically effective amount of L-4-chlorokynurenine, wherein the L-4-chlorokynurenine is administered in a daily dose of 360, 1080 or 1440 mg.
1 Assignment
0 Petitions
Accused Products
Abstract
Compositions of L-4-chlorokynurenine are provided, as are methods for the treatment of neurological dysfunction.
-
Citations
11 Claims
- 1. A method of treating depression comprising the step of orally administering to a human patient in need thereof a therapeutically effective amount of L-4-chlorokynurenine, wherein the L-4-chlorokynurenine is administered in a daily dose of 360, 1080 or 1440 mg.
- 10. A method of treating depression comprising the step of orally administering to a human patient in need thereof a pharmaceutical composition comprising a unit dose of 360, 1080 or 1440 mg of L-4-chlorokynurenine and a pharmaceutically acceptable carrier or excipient.
Specification